Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs.

Berit Ø ChristoffersenRikke Bjerring SkyggebjergAnne BuggeRikke Kaae KirkBill VestergaardHenriette Kold UldamJohannes Josef FelsCharles PykeUlrich SensfussAnnika SanfridsonTrine Ryberg Clausen

Published in: International journal of obesity (2005) (2019)

NN9056, a long-acting CCK-1 receptor-selective CCK analogue, significantly reduced food intake and BW in obese Göttingen Minipigs after once daily s.c. dosing for 13 weeks.

Keyphrases

body weight
adipose tissue
weight loss
metabolic syndrome
type diabetes
obese patients
bariatric surgery
gestational age
binding protein